inavolisib

Details

Key Milestones2
Call for patient/clinician input openJanuary 08, 2025
Call for patient/clinician input closedMarch 03, 2025
Submission receivedFebruary 19, 2025
Submission acceptedMarch 05, 2025
Review initiatedMarch 06, 2025
Draft CADTH review report(s) provided to sponsor for commentMay 23, 2025
Deadline for sponsors commentsJune 03, 2025
CDA-AMC review report(s) and responses to comments provided to sponsorJune 26, 2025
Expert committee meeting (initial)-
Draft recommendation issued to sponsor-
Draft recommendation posted for stakeholder feedback-
End of feedback period-

venetoclax

Details

Key Milestones2
Call for patient/clinician input openJanuary 08, 2025
Call for patient/clinician input closedMarch 03, 2025
Submission receivedFebruary 20, 2025
Submission acceptedMarch 06, 2025
Review initiatedMarch 07, 2025
Draft CADTH review report(s) provided to sponsor for commentMay 26, 2025
Deadline for sponsors commentsJune 04, 2025
CDA-AMC review report(s) and responses to comments provided to sponsorJune 26, 2025
Expert committee meeting (initial)July 09, 2025
Draft recommendation issued to sponsorAugust 07, 2025
Draft recommendation posted for stakeholder feedbackAugust 14, 2025
End of feedback periodAugust 28, 2025

abemaciclib

Details

Key Milestones2
Call for patient/clinician input openJanuary 08, 2025
Call for patient/clinician input closedMarch 03, 2025
Submission receivedFebruary 14, 2025
Submission acceptedMarch 11, 2025
Clarification:

- Submission was not accepted for review on 03 Mar 2025

Review initiatedMarch 12, 2025
Draft CADTH review report(s) provided to sponsor for commentMay 26, 2025
Deadline for sponsors commentsJune 04, 2025
CDA-AMC review report(s) and responses to comments provided to sponsorJune 26, 2025
Expert committee meeting (initial)July 09, 2025
Draft recommendation issued to sponsorJuly 21, 2025
Draft recommendation posted for stakeholder feedbackJuly 31, 2025
End of feedback periodAugust 15, 2025

teplizumab

Details

Key Milestones2
Call for patient/clinician input openJanuary 08, 2025
Call for patient/clinician input closedMarch 03, 2025
Submission receivedFebruary 19, 2025
Submission acceptedMarch 05, 2025
Review initiatedMarch 06, 2025
Draft CADTH review report(s) provided to sponsor for commentMay 28, 2025
Deadline for sponsors commentsJune 06, 2025
CDA-AMC review report(s) and responses to comments provided to sponsorJuly 11, 2025
Expert committee meeting (initial)July 23, 2025
Draft recommendation issued to sponsorAugust 06, 2025
Draft recommendation posted for stakeholder feedbackAugust 14, 2025
End of feedback periodAugust 28, 2025

abemaciclib

Details

Key Milestones2
Call for patient/clinician input openJanuary 08, 2025
Call for patient/clinician input closedMarch 03, 2025
Submission receivedFebruary 14, 2025
Submission acceptedMarch 03, 2025
Review initiatedMarch 04, 2025
Draft CADTH review report(s) provided to sponsor for commentMay 26, 2025
Deadline for sponsors commentsJune 04, 2025
CDA-AMC review report(s) and responses to comments provided to sponsorJune 26, 2025
Expert committee meeting (initial)July 09, 2025
Draft recommendation issued to sponsorJuly 22, 2025
Draft recommendation posted for stakeholder feedbackJuly 31, 2025
End of feedback periodAugust 15, 2025